Literature DB >> 30698690

New US Food and Drug Administration Approvals Decrease Generic Flucytosine Costs.

Radha Rajasingham1, David R Boulware1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30698690      PMCID: PMC6669281          DOI: 10.1093/cid/ciz037

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  4 in total

1.  Reconsidering cryptococcal antigen screening in the U.S. among persons with CD4 <100 cells/mcL.

Authors:  Radha Rajasingham; David R Boulware
Journal:  Clin Infect Dis       Date:  2012-08-23       Impact factor: 9.079

2.  Short-course High-dose Liposomal Amphotericin B for Human Immunodeficiency Virus-associated Cryptococcal Meningitis: A Phase 2 Randomized Controlled Trial.

Authors:  Joseph N Jarvis; Tshepo B Leeme; Mooketsi Molefi; Awilly A Chofle; Gabriella Bidwell; Katlego Tsholo; Nametso Tlhako; Norah Mawoko; Raju K K Patel; Mark W Tenforde; Charles Muthoga; Gregory P Bisson; Jeremiah Kidola; John Changalucha; David Lawrence; Shabbar Jaffar; William Hope; Si le F Molloy; Thomas S Harrison
Journal:  Clin Infect Dis       Date:  2019-01-18       Impact factor: 9.079

3.  Cryptococcal Meningitis Treatment Strategies Affected by the Explosive Cost of Flucytosine in the United States: A Cost-effectiveness Analysis.

Authors:  Matthew Merry; David R Boulware
Journal:  Clin Infect Dis       Date:  2016-03-23       Impact factor: 9.079

4.  Antifungal Combinations for Treatment of Cryptococcal Meningitis in Africa.

Authors:  Síle F Molloy; Cecilia Kanyama; Robert S Heyderman; Angela Loyse; Charles Kouanfack; Duncan Chanda; Sayoki Mfinanga; Elvis Temfack; Shabir Lakhi; Sokoine Lesikari; Adrienne K Chan; Neil Stone; Newton Kalata; Natasha Karunaharan; Kate Gaskell; Mary Peirse; Jayne Ellis; Chimwemwe Chawinga; Sandrine Lontsi; Jean-Gilbert Ndong; Philip Bright; Duncan Lupiya; Tao Chen; John Bradley; Jack Adams; Charles van der Horst; Joep J van Oosterhout; Victor Sini; Yacouba N Mapoure; Peter Mwaba; Tihana Bicanic; David G Lalloo; Duolao Wang; Mina C Hosseinipour; Olivier Lortholary; Shabbar Jaffar; Thomas S Harrison
Journal:  N Engl J Med       Date:  2018-03-15       Impact factor: 91.245

  4 in total
  3 in total

1.  Reply to Rajasingham and Boulware.

Authors:  Joseph N Jarvis; Thomas S Harrison
Journal:  Clin Infect Dis       Date:  2019-08-01       Impact factor: 9.079

2.  Adjunctive sertraline for asymptomatic cryptococcal antigenemia: A randomized clinical trial.

Authors:  David R Boulware; Elizabeth Nalintya; Radha Rajasingham; Paul Kirumira; Rose Naluyima; Fred Turya; Sylvia Namanda; Morris K Rutakingirwa; Caleb P Skipper; Yofesi Nikweri; Kathy Huppler Hullsiek; Ananta S Bangdiwala; David B Meya
Journal:  Med Mycol       Date:  2020-11-10       Impact factor: 4.076

3.  Antifungal drug price increases in the United States, 2000-2019.

Authors:  Christine M Thomas; Whitney Shae; Devin Koestler; Terese DeFor; Nathan C Bahr; Jonathan D Alpern
Journal:  Mycoses       Date:  2022-07-18       Impact factor: 4.931

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.